Rhabdomyolysis Clinical Trials

Find Rhabdomyolysis Clinical Trials Near You

Retrospective Evaluation of the Impact of Extrarenal Myoglobin Clearance on Renal Recovery in Patients With Severe Rhabdomyolysis

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Severe rhabdomyolysis is a common medical emergency that can lead to acute kidney injury (AKI), sometimes requiring extracorporeal renal replacement therapy (ECRT). Myoglobin plays a major role among the molecules involved in nephrotoxicity. While ECRT techniques are commonly used in this situation, their actual effectiveness in eliminating myoglobin and improving renal function remains poorly established. In particular, mid-cut-off membranes, developed to better remove intermediate molecular weight molecules, could improve renal prognosis. This study aims to evaluate, using retrospective clinical data, the impact of these techniques on renal recovery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Adult patient (≥18 years).

• Patient is hospitalized in the nephrology or medical intensive care units of the Strasbourg University Hospitals (NHC or Hautepierre) between 2015 and 2024.

• Confirmed diagnosis of severe rhabdomyolysis associated with acute kidney injury, with or without renal replacement therapy.

• Patient has not objected to the reuse of their medical data.

Locations
Other Locations
France
Service de Néphrologie Dialyse Transplantation - CHU de Strasbourg - France
RECRUITING
Strasbourg
Contact Information
Primary
Nans FLORENS, MD
nans.florens@chru-strasbourg.fr
33 3 69 55 13 25
Time Frame
Start Date: 2025-04-08
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Strasbourg, France

This content was sourced from clinicaltrials.gov